China starts using antiviral drug Remdesivir in clinical trials against Wuhan virus


Wang Chen (far right), vice president of the Chinese Academy of Engineering and president of the Chinese Academy of Medical Sciences, speaking at a conference in Wuhan on Feb. 5, 020. The registration for clinical trials on the antiviral drug Remdesivir has been approved, and the first batch of pneumonia patients infected by the novel coronavirus are to start taking the drug on Thursday (Fen 6). - Xinhua

BEIJING (Xinhua): The registration for clinical trials on the antiviral drug Remdesivir has been approved, and the first batch of pneumonia patients infected by the novel coronavirus (2019-nCoV) are expected to start taking the drug on Thursday (Feb 6), according to an official conference on Wednesday.

The approval is jointly supported by the Ministry of Science and Technology (MOST), the National Health Commission and the National Medical Products Administration.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

China , Wuhan , virus , antiviral , drug , Remdesivir , clinical , trials , Gilead , Sciences

   

Next In Regional

Acting legend Tony Leung, Nvidia chief Huang get honorary doctorates from HK uni
India reports 'good progress' in Asean-India trade pact review talks
KL in 50th spot as London crowned world's best city for 10th consecutive year
Malaysia commends Laos for successful Asean 2024 chairmanship
Supply chain snags: Airlines in Malaysia, Thailand among those affected as travel demand rebounds
41 passengers injured as Hong Kong ferry bumps into pier on Central’s waterfront
DPM Zahid emphasises shared goals in meeting with Philippines President Marcos
Malaysia’s strategies as Asean chair in 2025 focus on regional value chains, says Anwar
Asean Foreign Ministers' meeting kicks off in Laos ahead of 44th and 45th Asean Summits
Asean must remain neutral to boost regional investment, says Tengku Zafrul

Others Also Read